Prokidney (PROK) Change in Accured Expenses (2021 - 2026)

Prokidney (PROK) has 6 years of Change in Accured Expenses data on file, last reported at -$6.0 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$6.0 million, down 0.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.0 million (down 151.36% YoY), and the FY2025 annual result was -$5.9 million, down 151.06% from the prior year.
• Change in Accured Expenses retreated to -$6.0 million in Q1 2026 per PROK's latest filing, from $2.2 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $13.0 million in Q2 2023 and troughed at -$6.0 million in Q1 2026.
• A 5-year average of $697000.0 and a median of $104000.0 in 2024 frame the typical range for Change in Accured Expenses.
• On a YoY basis, Change in Accured Expenses climbed as much as 3452172.73% in 2022 and fell as far as 2317145.45% in 2022.
• A 5-year view of Change in Accured Expenses shows it stood at $533000.0 in 2022, then soared by 625.14% to $3.9 million in 2023, then jumped by 202.87% to $11.7 million in 2024, then slumped by 81.58% to $2.2 million in 2025, then slumped by 376.3% to -$6.0 million in 2026.
• Business Quant data shows PROK's Change in Accured Expenses at -$6.0 million in Q1 2026, $2.2 million in Q4 2025, and $51000.0 in Q3 2025.